Track market-moving stories before they get noisy

AI chips are fueling the latest technology. For example, chatbots, autonomous vehicles, and humanoid robots all need powerful parallel processors that can process massive amounts of data rapidly so they can respond to questions or what's happening in the environment around them in real-time.

However, when they're working, those AI chips get extremely hot, which can result in reduced performance, component damage, shortened chip lifespans, and even fires. That's why liquid cooling systems are a part of every data center. They prevent the chips from overheating, and those systems are as vital to the AI boom as the chips themselves.

Vertiv (VRT +0.75%) is among the leaders in data center liquid cooling. Its stock is up by more than 60% year to date, soundly outperforming the S&P 500 over that period. Its key role in AI infrastructure suggests that its momentum could be sustainable.

Image source: Getty Images.

More data centers increase the demand for liquid cooling solutions Vertiv's revenue growth will depend on the success of Nvidia and the continuation of the data center build-out. The leading chipmaker's 85% year-over-year revenue growth in its fiscal 2027 first quarter shows that chips are still in high demand. Each of those chips will need liquid cooling to actually function.

Today's Change

(

0.75

%) $

2.16

Current Price

$

291.72

The data center narrative is even more compelling. Market intelligence company Cleanview asserts that there are 1,214 large-scale data centers operating in the U.S., with another 1,714 data centers planned. The site also lists 55,509 megawatts in operating capacity, compared to 369,555 megawatts in planned capacity.

Iren's Childress site tops the list as the largest operating data center in the U.S., at 750 megawatts. Meanwhile, the nine largest data centers in development will all exceed 5 gigawatts. That indicates just how huge the market is for liquid cooling solutions of the type that Vertiv provides.

Vertiv's pricing power is growing Naturally, all of the upcoming data centers have boosted demand for Vertiv's services, which has given it strong pricing power. The company reported 30% year-over-year revenue growth in the first quarter while more than doubling its net income.

Vertiv's net profit margins comfortably sit in the double digits and may continue to inch higher if current growth rate trends prevail. Given the soaring demand for new data center capacity, that's likely. However, Vertiv also benefits since its services are required to maintain the liquid cooling systems it installs. Every new data center site represents a potential customer and a potential recurring revenue source.

In its Q1 report, management did not mention the company's backlog, but Vertiv wrapped up 2025 with a book-to-bill backlog of $15 billion, which was a 109% year-over-year increase. And Vertiv recently opened a new manufacturing facility in Malaysia so it can serve more customers, evidence that it expects AI demand to keep growing.

, /PRNewswire/ -- Ally Financial Inc. (NYSE: ALLY) today reported its second quarter 2026 results. View full press release in PDF.

The news release, presentation and financial supplement can be accessed in the following ways:

Ally Financial Press Room at https://media.ally.com Ally Financial Investor Relations website at https://ally.com/about/investor/ Ally will host a conference call at 9 a.m. ET to review the company's performance. The call will include a review of the results, followed by a question and answer session.

Conference Call Information: Conference call participation is available via webcast or dial-in. The webcast will be live on Ally's Investor Relations website in the Events & Presentations section (https://www.ally.com/about/investor/events-presentations/index.html).

To join the conference via dial-in, please pre-register via the following link at least 15 minutes before the call begins: https://register-conf.media-server.com/register/BIe8c04604b04f45b8bfc92dc71d60682f. Upon registration, you will be provided with the conference dial-in number as well as a unique registrant ID.

A replay of the call will be available via webcast on the Ally Investor Relations website.

About Ally Financial
Ally Financial Inc. (NYSE: ALLY) includes the nation's largest all-digital bank and auto finance business, driven by a mission to "Do It Right" for its customers and communities. Ally is a U.S. financial holding company with $200 billion in assets and 9.6 million customers (June 30, 2026). Ally Bank, Member FDIC, offers online banking products, including high-yield savings and no hidden fee checking, and was the first major U.S. bank to eliminate overdraft fees. Ally also provides investing solutions through Ally Invest, including online brokerage, automated investing, IRAs and personal advice. As a leader in auto finance, Ally provides consumer and dealer financing, insurance, and vehicle remarketing services. Ally's seasoned corporate finance business provides capital to equity sponsors and middle-market companies. Visit ally.com.

Contacts:

Sean Leary
Ally Investor Relations
704-444-4830
[email protected]

Peter Gilchrist
Ally Communications (Media)
704-644-6299
[email protected]

SOURCE Ally Financial

Posted by Defense World Staff on Jul 21st, 2026

Bank of New York Mellon Corp trimmed its holdings in shares of Timken Company (The) (NYSE:TKR – Free Report) by 7.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,034,111 shares of the industrial products company’s stock after selling 88,242 shares during the period. Bank of New York Mellon Corp owned about 1.48% of Timken worth $104,001,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Illinois Municipal Retirement Fund acquired a new position in shares of Timken in the first quarter worth $1,078,000. Checchi Capital Advisers LLC acquired a new stake in shares of Timken during the first quarter valued at $235,000. Calamos Advisors LLC acquired a new stake in shares of Timken during the first quarter valued at $299,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management purchased a new position in Timken in the 1st quarter valued at about $252,000. Finally, State of Michigan Retirement System boosted its stake in shares of Timken by 1.3% during the 1st quarter. State of Michigan Retirement System now owns 15,223 shares of the industrial products company’s stock worth $1,531,000 after purchasing an additional 200 shares during the last quarter. Hedge funds and other institutional investors own 89.08% of the company’s stock.

Timken Trading Down 2.5% Shares of TKR opened at $134.32 on Tuesday. Timken Company has a twelve month low of $70.57 and a twelve month high of $146.37. The firm has a market capitalization of $9.34 billion, a P/E ratio of 30.53, a price-to-earnings-growth ratio of 1.64 and a beta of 1.20. The company has a current ratio of 2.88, a quick ratio of 1.55 and a debt-to-equity ratio of 0.60. The stock’s fifty day simple moving average is $132.83 and its 200 day simple moving average is $112.49.

Timken (NYSE:TKR – Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The industrial products company reported $1.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.50 by $0.17. The firm had revenue of $1.23 billion during the quarter, compared to the consensus estimate of $1.17 billion. Timken had a return on equity of 11.84% and a net margin of 6.60%.The firm’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.40 earnings per share. Timken has set its FY 2026 guidance at 5.750-6.250 EPS. On average, equities research analysts forecast that Timken Company will post 6.16 earnings per share for the current year.

Timken Increases Dividend The firm also recently declared a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Tuesday, May 19th were given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 1.1%. This is a positive change from Timken’s previous quarterly dividend of $0.35. The ex-dividend date of this dividend was Tuesday, May 19th. Timken’s dividend payout ratio is presently 32.73%.

Insiders Place Their Bets In related news, Director Ajita G. Rajendra sold 8,450 shares of Timken stock in a transaction on Friday, June 5th. The shares were sold at an average price of $131.34, for a total transaction of $1,109,823.00. Following the transaction, the director owned 20,225 shares in the company, valued at approximately $2,656,351.50. The trade was a 29.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Richard G. Kyle sold 8,448 shares of the stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $127.35, for a total value of $1,075,852.80. Following the completion of the sale, the director owned 197,361 shares of the company’s stock, valued at approximately $25,133,923.35. This represents a 4.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 69,079 shares of company stock worth $8,296,144 over the last ninety days. 8.10% of the stock is owned by company insiders.

Analysts Set New Price Targets Several equities analysts recently issued reports on TKR shares. Weiss Ratings reissued a “hold (c+)” rating on shares of Timken in a research note on Friday. DA Davidson initiated coverage on Timken in a report on Tuesday, June 16th. They issued a “neutral” rating and a $130.00 price target for the company. The Goldman Sachs Group increased their price target on Timken from $128.00 to $142.00 and gave the stock a “neutral” rating in a research note on Friday, July 10th. KeyCorp lifted their price objective on Timken from $140.00 to $160.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. Finally, Morgan Stanley set a $140.00 target price on Timken in a research note on Thursday, May 21st. Six investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $149.62.

Get Our Latest Analysis on TKR

Timken Company Profile (Free Report)

The Timken Company is a global manufacturer specializing in engineered bearings and mechanical power transmission products. Its core offerings include tapered and cylindrical roller bearings, spherical and plain bearings, mounted bearing units, and precision gear drives. Timken’s products serve a broad range of industries, from industrial machinery and aerospace to automotive, rail, wind energy and heavy equipment.

Beyond bearings, Timken’s portfolio extends to industrial chains, belts, couplings and related components designed to optimize power transmission systems.

Recommended Stories Five stocks we like better than Timken The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding TKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Timken Company (The) (NYSE:TKR – Free Report).

Receive News & Ratings for Timken Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Timken and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEMicrosoft Corporation $MSFT Stake Lowered by Fishman Jay A Ltd. MI

NEXT HEADLINE »Microsoft Corporation $MSFT Shares Sold by Geneva Partners LLC

Posted by Defense World Staff on Jul 21st, 2026

California Public Employees Retirement System boosted its holdings in Teledyne Technologies Incorporated (NYSE:TDY – Free Report) by 1.1% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 83,155 shares of the scientific and technical instruments company’s stock after purchasing an additional 908 shares during the quarter. California Public Employees Retirement System owned about 0.18% of Teledyne Technologies worth $50,310,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of TDY. Assetmark Inc. lifted its position in shares of Teledyne Technologies by 10.5% during the 1st quarter. Assetmark Inc. now owns 190 shares of the scientific and technical instruments company’s stock valued at $115,000 after acquiring an additional 18 shares during the period. SteelPeak Wealth LLC grew its holdings in Teledyne Technologies by 110.5% in the first quarter. SteelPeak Wealth LLC now owns 1,871 shares of the scientific and technical instruments company’s stock worth $1,132,000 after purchasing an additional 982 shares during the period. Allspring Global Investments Holdings LLC grew its holdings in Teledyne Technologies by 1.0% in the first quarter. Allspring Global Investments Holdings LLC now owns 252,967 shares of the scientific and technical instruments company’s stock worth $156,326,000 after purchasing an additional 2,611 shares during the period. Wealthfront Advisers LLC increased its stake in Teledyne Technologies by 3.9% in the first quarter. Wealthfront Advisers LLC now owns 5,352 shares of the scientific and technical instruments company’s stock valued at $3,238,000 after purchasing an additional 199 shares in the last quarter. Finally, Twin Capital Management Inc. acquired a new position in shares of Teledyne Technologies during the first quarter valued at about $1,004,000. 91.58% of the stock is currently owned by institutional investors.

Teledyne Technologies Price Performance Shares of NYSE TDY opened at $627.21 on Tuesday. Teledyne Technologies Incorporated has a fifty-two week low of $483.02 and a fifty-two week high of $693.38. The stock has a market cap of $29.06 billion, a price-to-earnings ratio of 31.73, a PEG ratio of 3.04 and a beta of 0.92. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.16 and a current ratio of 1.76. The firm’s 50-day simple moving average is $626.31 and its 200 day simple moving average is $626.35.

Teledyne Technologies (NYSE:TDY – Get Free Report) last issued its quarterly earnings data on Wednesday, April 22nd. The scientific and technical instruments company reported $5.80 EPS for the quarter, topping analysts’ consensus estimates of $5.48 by $0.32. Teledyne Technologies had a return on equity of 10.24% and a net margin of 14.99%.The firm had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.52 billion. During the same period in the previous year, the company posted $4.95 EPS. The company’s revenue for the quarter was up 7.6% on a year-over-year basis. Teledyne Technologies has set its FY 2026 guidance at 23.850-24.150 EPS and its Q2 2026 guidance at 5.700-5.800 EPS. As a group, research analysts anticipate that Teledyne Technologies Incorporated will post 24.1 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In TDY has been the subject of several research reports. Citigroup raised their target price on Teledyne Technologies from $677.00 to $680.00 and gave the company a “neutral” rating in a research note on Wednesday, July 1st. Stifel Nicolaus upped their price target on Teledyne Technologies from $720.00 to $750.00 and gave the stock a “buy” rating in a research note on Thursday, April 23rd. Barclays increased their price target on Teledyne Technologies from $603.00 to $614.00 and gave the stock an “equal weight” rating in a report on Friday, April 24th. Jefferies Financial Group raised Teledyne Technologies to a “strong-buy” rating in a research note on Wednesday, June 10th. Finally, Needham & Company LLC boosted their price objective on Teledyne Technologies from $700.00 to $735.00 and gave the company a “buy” rating in a report on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $694.14.

Check Out Our Latest Analysis on Teledyne Technologies

About Teledyne Technologies (Free Report)

Teledyne Technologies (NYSE: TDY), headquartered in Thousand Oaks, California, is a diversified industrial technology company that designs, manufactures and supports sophisticated electronic systems, instruments and imaging products. Founded in 1960 by Henry Singleton and George Kozmetsky, Teledyne has grown into a multinational provider of high-performance equipment and software for commercial, scientific and government customers. Its offerings are used in markets that include aerospace and defense, marine, industrial manufacturing, environmental monitoring and scientific research.

The company operates through businesses that develop precision instrumentation, digital imaging products, engineered systems and aerospace and defense electronics.

Further Reading Five stocks we like better than Teledyne Technologies The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding TDY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teledyne Technologies Incorporated (NYSE:TDY – Free Report).

Receive News & Ratings for Teledyne Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teledyne Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEDollar General Corporation $DG Shares Sold by California Public Employees Retirement System

NEXT HEADLINE »California Public Employees Retirement System Cuts Stake in Hubbell Inc $HUBB

California Public Employees Retirement System boosted its position in PulteGroup, Inc. (NYSE:PHM – Free Report) by 4.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 420,701 shares of the construction company’s stock after purchasing an additional 16,536 shares during the period. California Public Employees Retirement System owned about 0.22% of PulteGroup worth $49,479,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in PHM. Focus Partners Wealth increased its position in shares of PulteGroup by 20.5% during the 1st quarter. Focus Partners Wealth now owns 12,517 shares of the construction company’s stock valued at $1,287,000 after purchasing an additional 2,128 shares during the last quarter. EverSource Wealth Advisors LLC boosted its holdings in shares of PulteGroup by 197.1% in the second quarter. EverSource Wealth Advisors LLC now owns 1,212 shares of the construction company’s stock worth $128,000 after buying an additional 804 shares during the last quarter. Guggenheim Capital LLC grew its position in PulteGroup by 12.9% during the second quarter. Guggenheim Capital LLC now owns 8,519 shares of the construction company’s stock valued at $898,000 after buying an additional 975 shares during the period. Baird Financial Group Inc. grew its position in PulteGroup by 8.0% during the second quarter. Baird Financial Group Inc. now owns 29,060 shares of the construction company’s stock valued at $3,065,000 after buying an additional 2,164 shares during the period. Finally, Cerity Partners LLC grew its position in PulteGroup by 17.6% during the second quarter. Cerity Partners LLC now owns 41,677 shares of the construction company’s stock valued at $4,395,000 after buying an additional 6,240 shares during the period. 89.90% of the stock is currently owned by institutional investors.

PulteGroup Trading Down 2.2% Shares of PulteGroup stock opened at $123.27 on Tuesday. PulteGroup, Inc. has a fifty-two week low of $108.32 and a fifty-two week high of $144.49. The company has a debt-to-equity ratio of 0.14, a quick ratio of 0.94 and a current ratio of 0.94. The company has a market capitalization of $23.48 billion, a P/E ratio of 11.92, a P/E/G ratio of 1.61 and a beta of 1.18. The company has a fifty day moving average of $123.07 and a 200 day moving average of $125.07.

PulteGroup (NYSE:PHM – Get Free Report) last posted its quarterly earnings results on Thursday, April 23rd. The construction company reported $1.79 EPS for the quarter, missing analysts’ consensus estimates of $1.80 by ($0.01). PulteGroup had a net margin of 12.14% and a return on equity of 16.41%. The business had revenue of $3.41 billion for the quarter, compared to the consensus estimate of $3.40 billion. During the same period in the prior year, the business earned $2.57 earnings per share. PulteGroup’s revenue was down 12.4% compared to the same quarter last year. On average, sell-side analysts anticipate that PulteGroup, Inc. will post 9.95 earnings per share for the current fiscal year.

PulteGroup Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Thursday, July 2nd. Investors of record on Tuesday, June 16th were paid a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend was Tuesday, June 16th. PulteGroup’s dividend payout ratio (DPR) is 10.06%.

PulteGroup declared that its board has authorized a stock buyback plan on Thursday, April 23rd that authorizes the company to buyback $1.50 billion in shares. This buyback authorization authorizes the construction company to purchase up to 6.1% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s board believes its stock is undervalued.

Analyst Ratings Changes Several research firms have weighed in on PHM. Weiss Ratings downgraded shares of PulteGroup from a “buy (b-)” rating to a “hold (c)” rating in a research report on Monday, April 27th. Truist Financial reduced their price objective on PulteGroup from $170.00 to $150.00 and set a “buy” rating for the company in a research note on Thursday, April 16th. Seaport Research Partners reaffirmed a “sell” rating and issued a $100.00 target price (down from $155.00) on shares of PulteGroup in a report on Tuesday, April 7th. Citigroup raised their target price on PulteGroup from $136.00 to $138.00 and gave the stock a “neutral” rating in a report on Friday, April 24th. Finally, Oppenheimer reiterated an “outperform” rating on shares of PulteGroup in a research report on Tuesday, May 26th. Ten analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $142.21.

Get Our Latest Stock Analysis on PulteGroup

Insider Activity at PulteGroup In other PulteGroup news, Director Lila Snyder sold 3,339 shares of the stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $117.18, for a total transaction of $391,264.02. Following the completion of the sale, the director directly owned 3,540 shares of the company’s stock, valued at $414,817.20. This trade represents a 48.54% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Matthew William Koart sold 7,457 shares of PulteGroup stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $120.00, for a total transaction of $894,840.00. Following the sale, the chief operating officer owned 28,100 shares in the company, valued at approximately $3,372,000. The trade was a 20.97% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.75% of the stock is currently owned by company insiders.

PulteGroup Company Profile (Free Report)

PulteGroup, Inc (NYSE: PHM) is a U.S.-based residential homebuilder that designs, constructs and sells single-family homes and develops master-planned communities. The company operates multiple national and regional brands that target different buyer segments, including first-time buyers, move-up buyers and active-adult customers. Its operations encompass land acquisition and development, home design and construction, community amenities and ongoing customer service and warranty programs.

PulteGroup markets homes under several well-known brands, such as Pulte Homes, Centex and Del Webb, among others, offering a range of product types from entry-level detached homes to larger, higher-end residences and age-restricted active-adult communities.

Recommended Stories Five stocks we like better than PulteGroup The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding PHM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PulteGroup, Inc. (NYSE:PHM – Free Report).

Receive News & Ratings for PulteGroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PulteGroup and related companies with MarketBeat.com's FREE daily email newsletter.

Posted by Defense World Staff on Jul 21st, 2026

Bank of New York Mellon Corp reduced its holdings in ITT Inc. (NYSE:ITT – Free Report) by 9.9% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 619,524 shares of the conglomerate’s stock after selling 68,403 shares during the quarter. Bank of New York Mellon Corp owned about 0.69% of ITT worth $118,038,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the business. Elyxium Wealth LLC purchased a new position in ITT during the 4th quarter valued at $29,000. Bayban purchased a new stake in shares of ITT in the 4th quarter worth about $31,000. Parkside Financial Bank & Trust boosted its stake in shares of ITT by 62.8% during the 4th quarter. Parkside Financial Bank & Trust now owns 197 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 76 shares in the last quarter. Triumph Capital Management purchased a new position in shares of ITT during the third quarter valued at about $37,000. Finally, Entrust Financial LLC purchased a new position in shares of ITT during the fourth quarter valued at about $36,000. 91.59% of the stock is owned by hedge funds and other institutional investors.

ITT Trading Down 0.7% ITT stock opened at $191.18 on Tuesday. ITT Inc. has a 12 month low of $155.58 and a 12 month high of $225.26. The company has a market capitalization of $17.09 billion, a price-to-earnings ratio of 33.72, a price-to-earnings-growth ratio of 1.81 and a beta of 1.27. The business’s fifty day simple moving average is $193.49 and its two-hundred day simple moving average is $195.21. The company has a current ratio of 1.53, a quick ratio of 1.01 and a debt-to-equity ratio of 0.71.

ITT (NYSE:ITT – Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The conglomerate reported $1.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.77 by $0.21. The firm had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.12 billion. ITT had a return on equity of 16.83% and a net margin of 10.80%.ITT’s quarterly revenue was up 32.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.45 EPS. ITT has set its FY 2026 guidance at 7.700-8.000 EPS. As a group, equities analysts predict that ITT Inc. will post 7.91 earnings per share for the current fiscal year.

ITT Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Monday, July 6th. Investors of record on Monday, June 8th were given a dividend of $0.386 per share. The ex-dividend date of this dividend was Monday, June 8th. This represents a $1.54 annualized dividend and a dividend yield of 0.8%. ITT’s dividend payout ratio (DPR) is 27.16%.

Wall Street Analysts Forecast Growth Several analysts have commented on ITT shares. The Goldman Sachs Group assumed coverage on shares of ITT in a report on Tuesday, March 31st. They issued a “buy” rating and a $270.00 price objective for the company. DA Davidson raised their target price on ITT from $245.00 to $255.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Wolfe Research upgraded ITT from a “peer perform” rating to an “outperform” rating and set a $229.00 price target on the stock in a research report on Thursday, July 9th. Citigroup upped their price target on ITT from $252.00 to $254.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Finally, Weiss Ratings cut shares of ITT from a “buy (b)” rating to a “buy (b-)” rating in a report on Wednesday, May 13th. Eleven investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $234.75.

View Our Latest Stock Analysis on ITT

Insider Buying and Selling In related news, insider Lori B. Marino sold 7,123 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $208.27, for a total value of $1,483,507.21. Following the transaction, the insider directly owned 8,729 shares of the company’s stock, valued at approximately $1,817,988.83. This represents a 44.93% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CAO Mesa Graziano Cheryl De sold 200 shares of the stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $208.41, for a total value of $41,682.00. Following the sale, the chief accounting officer owned 7,859 shares in the company, valued at approximately $1,637,894.19. This represents a 2.48% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.88% of the stock is owned by insiders.

ITT Company Profile (Free Report)

ITT Inc is a diversified industrial manufacturing company that designs, manufactures and services mission-critical components and systems for global markets. Its engineered solutions support applications in aerospace, defense, transportation, energy and industrial automation. The company focuses on delivering high-performance products that enable reliable fluid handling, precision motion control and robust connectivity in demanding environments.

The company’s operations are organized into three segments: Motion Technologies, which provides precision components and aftermarket repair services for aircraft engines and industrial turbines; Connect & Control Technologies, which offers specialty valves, couplings, seals and proximity sensors for fuel, hydraulics and environmental control systems; and Fluid & Motion Control, which delivers pumps, heat exchangers and fluid management solutions for oil and gas, chemical processing and power generation.

Read More Five stocks we like better than ITT The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for ITT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ITT and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEConning Inc. Has $11.06 Million Position in Alphabet Inc. $GOOGL

NEXT HEADLINE »Apple Inc. $AAPL Position Lessened by Fishman Jay A Ltd. MI

McLEAN, Va., July 21, 2026 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced that Michael DeBernardis has joined the company as vice president and chief counsel for its Mission Technologies division, HII’s global all-domain national security solutions business.

In this role, DeBernardis will advise senior leadership and lead the delivery of legal services for Mission Technologies. He will serve as a key member of the division’s leadership team, supporting its continued growth across defense, intelligence, cyber, unmanned systems, training, logistics, fleet sustainment, nuclear services, and mission-enabling capabilities and technologies.

DeBernardis brings nearly 20 years of experience advising global corporations, government contractors, and multinational organizations on complex legal, compliance, investigations, and governance matters.

Prior to joining HII, DeBernardis was the managing partner of the Washington, D.C., office of Hughes Hubbard & Reed LLP, where he also served as chair of the firm’s Global Investigations, Enforcement and Compliance practice.

A photo accompanying this release is available at: http://hii.com/news/hii-names-michael-debernardis-vice-president-and-chief-counsel-of-mission-technologies/.

DeBernardis has represented organizations before the U.S. Department of Justice, U.S. Securities and Exchange Commission, U.S. Senate permanent Subcommittee on Investigations, and numerous international development institutions.

“As HII continues to expand its integrated technology portfolio and deliver mission-enabling capabilities to customers around the world, Michael’s proven leadership, strategic judgment and deep experience navigating complex regulatory environments will be invaluable as we support our customers’ most critical missions,” said Andy Green, executive vice president and president of HII’s Mission Technologies division.

“Michael has a proven record of leading talented teams and solving some of the most complex legal challenges around the globe,” said Chad Boudreaux, executive vice president and chief legal officer of HII. “As chief counsel for Mission Technologies, he will continue to advance our company’s mission of delivering all-domain solutions in service of the nation, creating the advantage for customers to protect peace and freedom around the world.”

DeBernardis earned a Juris Doctor, cum laude, from George Washington University Law School, where he served on the International Law Review, and a Bachelor of Business Administration from the University of Delaware.

About HII

HII is America’s largest shipbuilder, delivering the world’s most powerful ships and all-domain mission technologies, including unmanned systems, to U.S. and allied defense customers. HII is the largest producer of unmanned underwater vehicles for the U.S. Navy and the world.

With a more than 140-year history of advancing U.S. national security, HII builds and integrates defense capabilities extending from the core fleet to C6ISR, AI/ML, EW and synthetic training. Headquartered in Virginia, HII’s workforce is 44,000 strong. For more information, visit:

HII on the web: https://www.HII.com/HII on Facebook: https://www.facebook.com/TeamHIIHII on X: https://www.twitter.com/WeAreHIIHII on Instagram: https://www.instagram.com/WeAreHIIHII on LinkedIn: https://www.linkedin.com/company/wearehii Contact:

Greg McCarthy
(202) 264-7126
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d36f28c9-6473-4e27-ab24-a3602f34df77

As we cross the halfway mark of 2026, the energy space has already experienced a dramatic shift in the macro landscape. Supply disruptions in the Middle East turned a looming oil supply glut into a severe shortage with depleted global inventories, benefiting U.S. energy companies across the value chain. Amid significant swings in oil and equities broadly, MLPs and midstream managed to outperform the S&P 500 and kept pace with the energy benchmark in 1H26. Midstream names also largely beat 1Q26 earnings estimates, with select companies raising EBITDA guidance for the full year. Learn more below about the key topics impacting MLPs and midstream in 1H26.

Key Takeaways Midstream had a strong first quarter and showcased its defensiveness in the second quarter. The sector held onto early gains as oil prices pulled back. Surging liquefied natural gas (LNG) export demand and power needs are driving record midstream backlogs and benefiting natural gas infrastructure companies. Midstream operators are rapidly building new pipeline takeaway capacity, which is starting to resolve Permian natural gas bottlenecks this year. Midstream Defends Gains Amid Oil Price Swings Energy was the best-performing sector in 1Q26 and the worst-performing sector in 2Q26, yet midstream stood out for its defensiveness. The Alerian MLP Infrastructure Index (AMZI) and Alerian Midstream Energy Select Index (AMEI) rose 0.9% and 0.8% on a total-return basis in the second quarter, holding on to their first-quarter gains of 17.2% and 23.4% respectively. By contrast, oil prices fell 31.5% in 2Q26 after a 76.6% gain in 1Q26, and the broader Energy Select Sector Index (IXE) retreated 12.5% following a 37.9% first-quarter gain.

Energy infrastructure companies’ defensiveness stems from the support of their fee-based business models, which provide some insulation from commodity price swings. Despite its 2Q26 weakness, the broader energy sector was the second best-performing sector in the first half of 2026, after information technology. Looking further ahead, the crude futures curve for 2027 shifted about $10 per barrel higher since the war began, resulting in a constructive production outlook for oil, natural gas, and natural gas liquids (NGLs).

North American Energy Export Demand Accelerates Middle Eastern supply disruptions have reinforced the global appeal of North American energy exports, including liquefied natural gas (LNG), crude, and NGLs. Besides triggering over 1.3 billion barrels of oil supply losses, the closure of the Strait of Hormuz cut off approximately 20% of global LNG supplies, mostly from Qatar, while also disrupting flows of NGLs including ethane, an industrial feedstock, and liquefied petroleum gas (LPG), widely used for cooking and heating.

This dynamic has paved the way for rapid export capacity expansions, and LNG companies have signed numerous long-term sales and purchase agreements with counterparties in Europe and Asia. The largest announcement this year came from LNG exporter Venture Global (VG), which sanctioned CP2 Phase 2, a multi-billion dollar project expected to make the company the largest U.S. LNG exporter.

Besides major new projects, VG and Cheniere Energy (LNG) have also announced bolt-on expansions for massive existing export terminals. Cheniere Energy Partners (CQP) expects to sanction a major expansion project to its Sabine Pass export terminal in early 2027, while Cheniere Energy is seeking to greenlight its CCL Expansion Phase 1 in mid-to-late 2027. A few LNG projects are also advancing in Canada.

On the liquids side, Energy Transfer (ET) is expanding its Nederland NGL terminal, and a joint venture including Canadian operator Keyera (KEY CN) is building the Alberta Corridor Export (ACE) rail terminal to expand LPG export capacity. Meanwhile, Enterprise Products Partners (EPD) is expediting Phase 2 of its Neches River NGL marine terminal expansion.

Power Demand Helps Drive Record Backlogs for Natural Gas Infrastructure Companies Alongside LNG, growing power needs in North America, including for data centers, is driving record backlogs for natural gas infrastructure companies. While this demand has been a tailwind for a couple of years, major developments this year include:

The significant expansion of Williams’ (WMB) direct power generation business, with a Blackstone-led consortium recently committing $5.3 billion for a 49% stake in five of WMB’s power projects; Pembina’s (PPL CN) move to sanction a C$4.6 billion power generation facility supporting a Meta data center; A 9.2 GW power campus being built by AEP and Japan’s SoftBank in Ohio powering new AI infrastructure that is likely to be supplied with natural gas by Kinder Morgan (KMI); and Midstream operators continuing to see strong customer interest for regional pipeline expansions to serve broader utility grids. The multi-billion-dollar backlogs for natural gas infrastructure names, spanning both projects under construction and future project pipelines, support a multi-year runway for highly visible, fee-based EBITDA growth. As a result, many midstream names focused on these opportunity sets have been able to raise their long-term guidance.

Permian Natural Gas Projects Coming Online In the Permian Basin, a surge in associated natural gas production has resulted in severe, longstanding pipeline bottlenecks. This excess supply is largely driven by rising gas-oil ratios (GORs) as the basin matures and its production mix gets gassier. Highlighting this trend, EPD expects natural gas and NGL production growth in the Permian to be 1.6x that of crude oil production growth. This gassier production mix, combined with steady rig activity, forced the West Texas Waha natural gas price benchmark into negative territory for months.

Fortunately, pipeline infrastructure relief is arriving. The natural gas price benchmark for West Texas (Waha) recently switched into positive territory after trading consistently in negative territory for months, coinciding with the start-up of Kinder Morgan’s Gulf Coast Express Expansion. The expansion serves as the basin’s first major relief valve for takeaway constraints. Additional relief is imminent, with several critical long-haul projects slated to come online over the next year.

As can be seen above, ET’s Hugh Brinson Pipeline and the joint venture backed Blackcomb Pipeline are both expected to start up in 2H26, and most planned natural gas pipeline capacity additions in 2026 and 2027 originate in Texas. By alleviating takeaway constraints, this incoming capacity will create a positive runway for continued production growth from the basin into 2027.

Bottom Line Midstream enters the second half of 2026 in a much stronger position than it started the year, bolstered by a constructive production outlook for 2027. Natural gas infrastructure momentum shows no signs of slowing, as companies execute on massive opportunities tied to surging LNG and data center power demand. Moving forward, investors should monitor upcoming final investment decisions (FIDs) on export facilities and power-adjacent infrastructure, as well as broader trends in capital allocation. As earnings season kicks off in late July and early August, watch for potential upside to full-year EBITDA guidance alongside updates on dividend growth and share repurchases.

Looking for midstream insights in your inbox? Subscribe here to keep a pulse on midstream investing through our weekly updates.

AMZI is the underlying index for the Alerian MLP ETF (AMLP) and the ETRACS Alerian MLP Infrastructure Index ETN Series B (MLPB). AMEI is the underlying index for the Alerian Energy Infrastructure ETF (ENFR) and the Alerian Energy Infrastructure Portfolio (ALEFX).

Related Research: U.S. Oil Production Outlook & Midstream Implications

Midstream: Robust Gas Backlogs Drive Growth Visibility

Surging U.S. Power Needs Drive Gas Infrastructure Opportunity

WMB Analyst Day: Power & Pipe to Drive Robust Growth

Midstream and Rising Canadian Production & Exports

Midstream Prepares for More Permian Natural Gas

vettafi.com is owned by VettaFi LLC (“VettaFi”). VettaFi is the index provider for AMLP, MLPB, ENFR, and ALEFX, for which it receives an index licensing fee. However, AMLP, MLPB, ENFR, and ALEFX are not issued, sponsored, endorsed or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing or trading of AMLP, MLPB, ENFR, and ALEFX.

For more news, information, and analysis, visit the Energy Infrastructure Content Hub.

Americké futures kontrakty posilují, Nasdaq 100 futures +1,36 %

Posted by Defense World Staff on Jul 21st, 2026

Bessemer Group Inc. raised its stake in Highwoods Properties, Inc. (NYSE:HIW – Free Report) by 42.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 219,980 shares of the real estate investment trust’s stock after purchasing an additional 65,389 shares during the period. Bessemer Group Inc. owned 0.20% of Highwoods Properties worth $4,710,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in HIW. Caitong International Asset Management Co. Ltd increased its position in Highwoods Properties by 88.6% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 792 shares of the real estate investment trust’s stock valued at $25,000 after buying an additional 372 shares in the last quarter. California State Teachers Retirement System boosted its holdings in Highwoods Properties by 0.5% in the second quarter. California State Teachers Retirement System now owns 98,051 shares of the real estate investment trust’s stock worth $3,048,000 after acquiring an additional 489 shares in the last quarter. The Manufacturers Life Insurance Company grew its stake in shares of Highwoods Properties by 3.0% during the fourth quarter. The Manufacturers Life Insurance Company now owns 19,896 shares of the real estate investment trust’s stock worth $514,000 after acquiring an additional 572 shares during the last quarter. Maryland State Retirement & Pension System increased its holdings in shares of Highwoods Properties by 3.3% during the fourth quarter. Maryland State Retirement & Pension System now owns 22,218 shares of the real estate investment trust’s stock valued at $574,000 after acquiring an additional 720 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Highwoods Properties by 33.7% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 3,159 shares of the real estate investment trust’s stock valued at $82,000 after acquiring an additional 797 shares in the last quarter. 96.31% of the stock is currently owned by institutional investors.

Highwoods Properties Trading Down 1.0% HIW stock opened at $32.98 on Tuesday. The company’s 50-day simple moving average is $28.95 and its 200-day simple moving average is $25.69. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 1.46. Highwoods Properties, Inc. has a 52-week low of $20.45 and a 52-week high of $33.88. The firm has a market cap of $3.64 billion, a P/E ratio of 39.26 and a beta of 1.07.

Highwoods Properties (NYSE:HIW – Get Free Report) last announced its earnings results on Tuesday, April 28th. The real estate investment trust reported $0.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.13. Highwoods Properties had a return on equity of 3.97% and a net margin of 11.64%.The firm had revenue of $214.03 million for the quarter, compared to analyst estimates of $209.06 million. During the same quarter last year, the firm posted $0.83 EPS. The business’s revenue was up 6.8% on a year-over-year basis. Highwoods Properties has set its FY 2026 guidance at 3.400-3.68 EPS. As a group, equities analysts forecast that Highwoods Properties, Inc. will post 3.53 EPS for the current fiscal year.

Highwoods Properties declared that its board has authorized a stock repurchase plan on Wednesday, April 22nd that permits the company to repurchase $250.00 million in outstanding shares. This repurchase authorization permits the real estate investment trust to purchase up to 9.5% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

Highwoods Properties Announces Dividend The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 9th. Investors of record on Monday, May 18th were issued a $0.50 dividend. The ex-dividend date of this dividend was Monday, May 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 6.1%. Highwoods Properties’s dividend payout ratio is currently 238.10%.

Analyst Ratings Changes A number of research analysts have issued reports on the stock. Weiss Ratings upgraded shares of Highwoods Properties from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 9th. Wall Street Zen raised shares of Highwoods Properties from a “sell” rating to a “hold” rating in a report on Monday, March 23rd. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $28.00 target price on shares of Highwoods Properties in a research report on Thursday, May 14th. Wells Fargo & Company raised their target price on Highwoods Properties from $24.00 to $26.00 and gave the stock an “equal weight” rating in a research note on Monday, June 1st. Finally, Truist Financial lifted their price target on Highwoods Properties from $23.00 to $30.00 and gave the stock a “hold” rating in a research report on Friday, June 26th. Two equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, Highwoods Properties has a consensus rating of “Hold” and an average target price of $28.11.

View Our Latest Stock Analysis on HIW

Highwoods Properties Company Profile (Free Report)

Highwoods Properties, Inc is a publicly traded real estate investment trust (REIT) that acquires, develops, leases and manages office properties. The company’s portfolio is primarily focused on Class A office space, with an emphasis on high-quality buildings in key urban and suburban submarkets. Highwoods seeks to generate long-term, recurring revenues through a mix of in-place lease renewals, strategic dispositions and build-to-suit developments. Its asset management platform drives operational efficiencies and tenant service initiatives across its holdings.

Founded in 1970 and headquartered in Raleigh, North Carolina, Highwoods Properties has expanded its presence to eight major metropolitan regions across the Southeastern United States and Texas.

Read More Five stocks we like better than Highwoods Properties The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Highwoods Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Highwoods Properties and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBessemer Group Inc. Sells 69,600 Shares of Revolution Medicines, Inc. $RVMD

NEXT HEADLINE »Bessemer Group Inc. Grows Stake in iShares Preferred and Income Securities ETF $PFF

Collaboration combines more than 9,000 KetaMist® patient treatments with PharmaTher's prior FDA-approved ketamine experience

Pursuing an efficient FDA development pathway toward approval for treatment-resistant depression and other potential indications, leveraging KetaMist's real-world treatment foundation

KetaMist represents a differentiated, patient-controlled ketamine platform with the potential to build a multi-indication ketamine franchise

Toronto, Ontario--(Newsfile Corp. - July 21, 2026) - PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF) ("PharmaTher" or the "Company"), a specialty pharmaceutical company focused on personalized medicines for peptides and psychedelics, today announced a collaboration with Curtis W. Cassidy, M.D., the inventor and developer of KetaMist® (ketamist.com), a needle-free ketamine treatment platform, to pursue U.S. Food and Drug Administration ("FDA") approval for treatment-resistant depression (TRD) and other neuropsychiatric and medical conditions where ketamine has demonstrated therapeutic benefit.

KetaMist is a proprietary, patient-controlled and needle-free ketamine treatment platform developed by Dr. Cassidy for patients with treatment-resistant depression and other conditions. According to Dr. Cassidy, KetaMist has been used in more than 9,000 patient treatments, creating a meaningful body of real-world clinical experience that PharmaTher believes may support an efficient and potentially expedited FDA development strategy.

Targeting the Large and Growing TRD Market While Building a Ketamine Franchise

Treatment-resistant depression represents a significant unmet medical need, affecting millions of patients in the United States who do not respond adequately to standard antidepressant therapies. The current FDA-approved ketamine-based therapy for TRD, Spravato® (esketamine nasal spray), has demonstrated strong commercial traction, generating approximately $1.7 billion in worldwide sales in 2025, with trailing twelve-month sales through June 30, 2026 of approximately $2.0 billion.1 Analysts have reportedly projected that Spravato could generate approximately $3 billion in annual sales by 2027 and up to $5 billion in peak annual sales, highlighting the significant commercial opportunity for differentiated ketamine-based treatments.2

PharmaTher believes KetaMist has the potential to compete in this large and growing market by offering a differentiated treatment approach that may address certain limitations associated with existing therapies.

KetaMist is designed as a patient-controlled and needle-free delivery system, which may offer several potential advantages, subject to FDA approval:

Personalized dosing and administration, allowing physicians to tailor treatment to individual patient response;Simplified delivery method, potentially improving patient comfort and accessibility;Potential for broader clinical adoption, depending on regulatory requirements and labeling; andUse of racemic ketamine, which may provide a differentiated pharmacological profile compared to esketamine.Beyond TRD, PharmaTher views KetaMist as a franchise platform with the potential to be developed across multiple indications where ketamine has already demonstrated clinical utility, including but not limited to depression, anxiety disorders, post-traumatic stress disorder (PTSD), chronic pain, and other neuropsychiatric and neurological conditions. While many of these uses are currently off-label, the Company believes KetaMist's flexible and personalized delivery approach may support expansion into additional therapeutic areas over time, subject to regulatory approval.

A Potentially Expedited Path Toward FDA Approval

PharmaTher and Dr. Cassidy plan to work with the FDA to find an efficient path to approval for KetaMist.

Because ketamine is already an FDA-approved drug, the Company may be able to build on existing knowledge. KetaMist has already been used in more than 9,000 patient treatments, providing real-world experience on how the therapy is administered, how patients respond, and overall safety. PharmaTher will prepare regulatory documents to help guide discussions with the FDA toward a potentially expedited approval pathway.

Leveraging PharmaTher's FDA-Approved Ketamine Foundation

PharmaTher previously obtained FDA approval for Ketamine Hydrochloride Injection USP under ANDA #217858, demonstrating the Company's ability to complete the regulatory, manufacturing, analytical and quality requirements necessary to secure an FDA ketamine approval.

Although PharmaTher completed its sale of its ANDA in December 2025, the Company retained its rights to pursue non-generic ketamine opportunities, including new formulations, delivery technologies and therapeutic indications. PharmaTher also retained significant regulatory and product-development experience generated through the successful ANDA program.

As part of the KetaMist collaboration, PharmaTher intends to apply its ketamine regulatory, analytical and chemistry, manufacturing and controls experience to the KetaMist development program and seek FDA feedback on the most efficient pathway toward approval.

Positioned at the Intersection of Ketamine, Personalized Medicine and Regulatory Momentum

The collaboration follows PharmaTher's recently announced strategy to advance personalized medicines for peptides and psychedelics through differentiated products, enabling technologies and regulatory pathways.

KetaMist is aligned with that strategy because its patient-controlled delivery approach is intended to allow treatment to be adjusted to individual patient response rather than relying solely on a standardized administration model.

Importantly, PharmaTher believes KetaMist's design supports its development as a multi-indication ketamine franchise, leveraging the well-established pharmacology of ketamine and its broad therapeutic potential across numerous conditions.

The program also arrives during a period of increased U.S. regulatory attention toward ketamine and innovative mental-health treatments.

PharmaTher believes that recent regulatory precedents demonstrate increasing openness to development strategies that incorporate real-world data and leverage existing clinical experience to support more efficient pathways to approval. While each program is evaluated independently by the FDA, these precedents may provide a framework for engaging with regulators on potential expedited development approaches.

"KetaMist fits our strategy perfectly-a doctor-developed ketamine treatment with over 9,000 patient uses and a path to FDA approval. While we are initially focused on treatment-resistant depression, we believe KetaMist represents a broader franchise opportunity across multiple indications where ketamine has already shown clinical benefit. By combining this real-world experience with our prior FDA-approved ketamine work, we believe we can move faster and more efficiently than traditional drug development and unlock meaningful value across several large markets," said Fabio Chianelli, Chief Executive Officer of PharmaTher.

Dr. Curtis W. Cassidy commented: "I developed KetaMist to give physicians and patients a more personalized and accessible approach to ketamine treatment. After more than 9,000 patient treatments, we have gained substantial practical experience regarding how patients respond and how treatment may be individualized across a range of conditions. PharmaTher shares that focus on personalized medicine and has the pharmaceutical-development and FDA experience needed to take the next important step toward broader access and potential regulatory approval."

Near-Term Development Priorities

The collaboration activities will include preparing an FDA meeting package to obtain guidance for a potentially accelerated path toward FDA approval.

Near-term milestones are expected to include regulatory engagement with the FDA, definition of the clinical and data requirements for a potential NDA submission, and evaluation of how existing real-world data may support the development program.

The collaboration agreement provides PharmaTher with a one-year evaluation period to assess KetaMist for potential development and commercial testing. During this period, the parties may negotiate and enter into one or more additional agreements (each a "Possible Transaction") relating to the further development and commercialization of KetaMist, subject to mutually acceptable terms.

KetaMist is not currently approved by the FDA, and its existing clinical use is considered off-label. There can be no assurance that the FDA will accept the proposed regulatory pathway, that the existing treatment information will be suitable for regulatory use, or that KetaMist will receive FDA approval.

About KetaMist®

KetaMist® is a proprietary, patient-controlled and needle-free ketamine treatment platform developed to provide a more personalized approach for patients with treatment-resistant depression and other neuropsychiatric and medical conditions. The system is designed to allow physicians to tailor dosing and administration based on individual patient response, offering flexibility compared to traditional ketamine delivery methods.

KetaMist has been used in more than 9,000 patient treatments, generating meaningful real-world clinical experience related to dosing, administration, safety observations and patient outcomes. For more information, visit Ketamist.com.

About PharmaTher

PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF) is a specialty pharmaceutical company focused on developing, acquiring and commercializing personalized medicines and enabling technologies, with an emphasis on peptides and psychedelics. For more information, visit PharmaTher.com.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Cautionary and Forward-Looking Statements

This news release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable Canadian securities laws, collectively referred to as "forward-looking information." Forward-looking information is often identified by words such as "believe," "expect," "plan," "intend," "may," "could," "would," "should," "anticipate," "potential," "proposed," "target," "seek," "estimate," "forecast," "position," "develop," "advance," "expedite," "accelerate," "commercialize" and similar expressions, or statements that certain events or conditions "will," "may" or "could" occur.

This press release contains forward-looking statements regarding, among other matters, the collaboration with Dr. Cassidy, the evaluation and development of KetaMist, the proposed regulatory pathway, the potential use of real-world data, future FDA interactions, required studies, intellectual-property, development, and commercial opportunities, possible transaction, and the potential submission or approval of an NDA. Forward-looking statements are based on management's current expectations and assumptions and are subject to regulatory, clinical, manufacturing, intellectual-property, financing, competitive and other risks and uncertainties. There can be no assurance that the FDA will agree with the proposed development plan, that available data will be suitable for regulatory purposes, that required studies will be successful, that sufficient financing or partnerships will be obtained, or that KetaMist will receive regulatory approval or achieve commercialization.

Forward-looking information is based on management's current expectations, estimates, forecasts, beliefs and assumptions as of the date of this news release. Material assumptions include, without limitation, that: the collaboration will remain in effect and the parties will perform their respective obligations; information regarding prior KetaMist treatments is accurate, complete, accessible and capable of being reviewed or organized for regulatory purposes; the Company will be able to engage with the FDA within anticipated timelines; the FDA will provide guidance that permits a feasible development pathway; any required studies can be designed, funded and successfully completed; suitable manufacturing, analytical, clinical and supply-chain capabilities can be obtained; the Company will have access to sufficient capital, personnel and third-party expertise; intellectual-property and commercial rights can be maintained or secured; the Company will enter into one or more possible transactions; applicable laws and regulatory policies will not change in a materially adverse manner; and market-size information, commercial estimates and third-party analyst forecasts referenced in this news release are reasonably accurate. These assumptions may prove to be incorrect. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that could cause actual results, events or achievements to differ materially from those expressed or implied. Such risks include, without limitation: the possibility that the FDA may not agree with the Company's proposed development or regulatory strategy; that KetaMist may not qualify for an expedited or accelerated pathway; that the FDA may require substantial additional non-clinical, clinical, manufacturing, human-factors or other studies; that real-world data or information from prior patient treatments may be incomplete, inconsistent, retrospective, unverifiable or unsuitable for regulatory reliance; that existing treatment experience may not demonstrate safety or efficacy to the FDA's satisfaction; that studies may be delayed, unsuccessful or more costly than expected; and that KetaMist may never receive regulatory approval.

Readers are cautioned not to place undue reliance on forward-looking information, which speaks only as of the date of this news release. Except as required by applicable law, PharmaTher undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. Additional risk factors are described in the Company's continuous disclosure filings available under the Company's profile on SEDAR+. The forward-looking information contained in this news release is expressly qualified by this cautionary statement.

This news release does not constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful.

Footnotes

Johnson & Johnson, "Johnson & Johnson Reports Q4 and Full-Year 2025 Results," January 21, 2026, reporting worldwide Spravato sales of $1.696 billion for the year ended December 31, 2025; and Johnson & Johnson, "Johnson & Johnson Reports Q2 2026 Results, Raises 2026 Outlook," July 15, 2026, reporting worldwide Spravato sales of $1.052 billion for the six months ended June 30, 2026, compared with $734 million for the corresponding six-month period in 2025. Trailing twelve-month sales through June 30, 2026 were calculated as follows: $1.696 billion less $734 million, plus $1.052 billion, equalling approximately $2.014 billion. Figures may not add precisely due to rounding."Johnson & Johnson's Spravato Sales Growth Signals Upside for Psychedelic Drug Opportunity: Jefferies," April 14, 2026. The report stated that Jefferies projected Spravato annual sales of approximately $3 billion by 2027, $3.5 billion by 2028 and potential peak annual sales of up to $5 billion. These projections are analyst estimates and are not guarantees of future performance.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305777

Source: PharmaTher Holdings Ltd.

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

, /PRNewswire/ -- Oncor Electric Delivery Company LLC ("Oncor") plans to release its second quarter 2026 results on August 6, prior to Sempra's (NYSE: SRE) second quarter 2026 results conference call. Oncor's earnings release will be available on Oncor's website, oncor.com.

Sempra executives will host a conference call at 12 p.m. ET on Thursday, August 6 that will include discussion of Oncor's second quarter 2026 operational and financial results. Investors, media, analysts and the public may listen to a live webcast of the conference call by registering on the Investors section of Sempra's website and clicking on the appropriate link. Prior to the conference call, an accompanying slide presentation will be posted on sempra.com/investors.

For those unable to obtain access to the live webcast, it will be available on replay a few hours after its conclusion at sempra.com/investors.

Oncor's Quarterly Report on Form 10-Q for the period ended June 30, 2026 will be filed with the U.S. Securities and Exchange Commission after Sempra's conference call and, once filed, will also be available at oncor.com. 

Headquartered in Dallas, Oncor Electric Delivery Company LLC is a regulated electricity transmission and distribution business that uses superior asset management skills to provide reliable electricity delivery to consumers. Oncor (together with its subsidiaries) operates the largest transmission and distribution system in Texas, delivering electricity to more than 4.1 million homes and businesses and operating more than 145,000 circuit miles of transmission and distribution lines in Texas. While Oncor is owned by two investors (indirect majority owner, Sempra, and minority owner, Texas Transmission Investment LLC), Oncor is managed by its Board of Directors, which is comprised of a majority of disinterested directors.

SOURCE Oncor Electric Delivery Company LLC

Posted by Defense World Staff on Jul 21st, 2026

Andra AP fonden grew its holdings in DoorDash, Inc. (NASDAQ:DASH – Free Report) by 44.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 154,300 shares of the company’s stock after purchasing an additional 47,160 shares during the period. Andra AP fonden’s holdings in DoorDash were worth $23,168,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Norges Bank purchased a new stake in DoorDash in the 4th quarter valued at about $1,093,650,000. Wellington Management Group LLP boosted its stake in DoorDash by 593.1% during the fourth quarter. Wellington Management Group LLP now owns 5,481,693 shares of the company’s stock worth $1,241,494,000 after buying an additional 4,690,744 shares during the period. Price T Rowe Associates Inc. MD increased its position in shares of DoorDash by 32.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,958,114 shares of the company’s stock valued at $3,161,234,000 after acquiring an additional 3,447,754 shares during the last quarter. Coatue Management LLC increased its position in shares of DoorDash by 77.8% during the fourth quarter. Coatue Management LLC now owns 4,365,365 shares of the company’s stock valued at $988,668,000 after acquiring an additional 1,910,488 shares during the last quarter. Finally, Alyeska Investment Group L.P. purchased a new stake in shares of DoorDash in the 4th quarter valued at approximately $372,128,000. 90.64% of the stock is owned by institutional investors and hedge funds.

DoorDash Price Performance Shares of DASH opened at $189.02 on Tuesday. The company has a market cap of $82.36 billion, a P/E ratio of 90.01 and a beta of 1.78. DoorDash, Inc. has a fifty-two week low of $143.30 and a fifty-two week high of $285.50. The company has a quick ratio of 1.43, a current ratio of 1.43 and a debt-to-equity ratio of 0.27. The firm’s 50 day moving average price is $170.39 and its 200 day moving average price is $177.02.

DoorDash (NASDAQ:DASH – Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.36 by $0.06. The company had revenue of $4.04 billion during the quarter, compared to analysts’ expectations of $4.15 billion. DoorDash had a net margin of 6.29% and a return on equity of 9.58%. The firm’s revenue was up 33.1% compared to the same quarter last year. During the same quarter last year, the company posted $0.44 EPS. On average, research analysts forecast that DoorDash, Inc. will post 2.39 earnings per share for the current fiscal year.

Insiders Place Their Bets In related news, CFO Ravi Inukonda sold 19,095 shares of the business’s stock in a transaction on Wednesday, July 8th. The stock was sold at an average price of $188.04, for a total transaction of $3,590,623.80. Following the completion of the transaction, the chief financial officer directly owned 252,443 shares of the company’s stock, valued at $47,469,381.72. The trade was a 7.03% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stanley Tang sold 23,125 shares of the company’s stock in a transaction dated Thursday, July 2nd. The stock was sold at an average price of $191.19, for a total value of $4,421,268.75. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 74,927 shares of company stock valued at $13,241,532. 5.83% of the stock is owned by company insiders.

Analysts Set New Price Targets DASH has been the topic of several recent analyst reports. Stifel Nicolaus decreased their price objective on shares of DoorDash from $215.00 to $185.00 and set a “hold” rating on the stock in a report on Monday, April 13th. BTIG Research decreased their price target on DoorDash from $280.00 to $225.00 and set a “buy” rating on the stock in a research note on Friday, June 12th. The Goldman Sachs Group set a $280.00 price target on DoorDash in a research report on Thursday, May 7th. Wedbush initiated coverage on DoorDash in a research note on Thursday, July 16th. They issued a “neutral” rating and a $205.00 price objective for the company. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $265.00 price objective on shares of DoorDash in a report on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, twenty-four have issued a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, DoorDash presently has an average rating of “Moderate Buy” and an average target price of $252.89.

View Our Latest Analysis on DoorDash

DoorDash Profile (Free Report)

DoorDash, Inc operates a technology-driven logistics and food-delivery marketplace that connects consumers, merchants and independent delivery contractors. The company’s core service enables customers to order from local restaurants and retailers through its app and website while DoorDash handles last-mile fulfillment via its network of drivers, known as “Dashers.” Over time the platform has broadened beyond restaurant deliveries to include groceries, convenience items and retail deliveries, positioning DoorDash as a broader on-demand logistics provider for consumer goods.

In addition to its marketplace, DoorDash offers a suite of products and services for consumers and businesses.

Featured Stories Five stocks we like better than DoorDash The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for DoorDash Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DoorDash and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINENewmont Corporation $NEM Shares Sold by Andra AP fonden

NEXT HEADLINE »Intuitive Surgical, Inc. $ISRG Shares Purchased by Andra AP fonden

PAWTUCKET, R.I.--(BUSINESS WIRE)--Hasbro, Inc. (NASDAQ: HAS), a leading games, IP, and toy company, today reported financial results for the second quarter 2026. "Hasbro posted another quarter of topline growth, led by Wizards of the Coast," said Chris Cocks, Hasbro Chief Executive Officer. "Magic: The Gathering eclipsed $500 million in quarterly revenue for the first time in its 30-plus year history, led by the record-breaking debut of Marvel Super Heroes. With strong indications for our remai.

July 21, 2026 Monday's MarketsS&P 500
7,443 (-0.19%)Nasdaq
25,508 (-0.05%)Dow
51,839 (-0.59%)Bitcoin
$65,045 (+1.06%)

Source: Image created by Jester AI.

1. Nebius Rises on Nvidia Ownership Reveal Nebius (NBIS +2.70%) rose over 6% in pre-market trading after Nvidia (NVDA +0.25%) disclosed a 9.3% passive stake in the business, which partly includes the $2 billion investment Nvidia publicly announced in March. Nvidia moved around 1% higher as part of a tech rebound this morning, with Nasdaq futures up 1.3%.

A strategic shift to ecosystem lock-in: The overall investment from Nvidia allows it to directly finance the expansion of its own order book, along with providing Nebius with the financial backing to take on larger peers. "Businesses and governments are demanding more AI compute than the industry can supply": Fool analyst Tim Beyers explained in October last year that the Rule Breakers team were banking profit from the 2018 recommendation of Nebius, having outperformed the S&P 500 by 94%. However, he said "you may strongly consider merely holding your shares if you believe that the (AI compute) flywheel will keep spinning." 2. Trump Slaps 50% Tariffs on Canadian Goods President Trump has announced 50% tariffs on certain Canadian exports to the U.S. ranging from "wine to hockey sticks to cement," in a response to what he believes is trade discrimination on U.S. goods.

Tariffs set to take effect 30 days after Trump signs: The statement from the White House noted alleged unfair duties from Canada on autos, alcohol, and dairy products. The retaliatory actions will apply to Canadian goods regardless of whether it originates under the U.S.-Mexico-Canada Agreement (USMCA). Initial market reaction isn't one of panic: S&P 500 futures rose around 0.5% following the news, potentially indicating the stance from the U.S. could be eased in the coming month if both sides come to the negotiating table.

3. Next Up: Stock Advisor Recs HAS, EQT, and IBKR Report

Hasbro (HAS +0.05%) rose around 2% ahead of the market open as results showed solid growth, with full-year guidance upgraded as a result. Revenue rose by 16% versus the previous year with "broad-based strength across the business" noted for the longtime Team Rule Breakers rec in SA. EQT (EQT 1.03%) posts earnings following the closing bell, coming off the back of beating earnings expectations from the previous quarter. The Team Hidden Gems rec will be aiming to consolidate after the record production volumes from fiscal Q1. Interactive Brokers (IBKR +1.27%) is set to report after the market closes. The rec from Team HG is expected to deliver a 21.6% revenue increase versus the same period last year, driven by higher client activity, just like last quarter 5. Today's Take: Growth vs. Scale

I generally think of growth versus scale in terms of margins. When a company is simply growing, its revenue goes up, but its costs go up just as fast (or even faster). On the other hand, when a company is scaling, revenue is growing faster than its underlying costs, and margins improve over time.-- Matt Frankel Team Hidden Gems

Consider a meal-kit company that spends heavily on discounts and marketing to acquire customers. Signups climb quickly, but if those customers churn after a few boxes, the company has only bought growth at a high price. Acquisition costs outrun the revenue they generate.-- Nick Sciple Team Rule Breakers

5. Your Take Last week, Cathie Wood's ARK Invest made SpaceX (SPCX 3.20%) its largest purchase by value, adding roughly $56.9 million to its stake, while its biggest sale was a $39.2 million trim of AMD (AMD +1.58%).

Have you ever bought or sold a stock partly because a famous investor did? How did it work out, and what did you learn from following someone else's lead?

Discuss with friends and family, or become a member to hear what your fellow Fools are saying!

This image and article was created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices, EQT, Interactive Brokers Group, and Nvidia. The Motley Fool recommends Hasbro and recommends the following options: long January 2027 $43.75 calls on Interactive Brokers Group and short January 2027 $46.25 calls on Interactive Brokers Group. The Motley Fool has a disclosure policy.

Hasbro (HAS - Free Report) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $1.17 per share. This compares to earnings of $1.3 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +9.40%. A quarter ago, it was expected that this toy maker would post earnings of $1.12 per share when it actually produced earnings of $1.47, delivering a surprise of +31.25%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Hasbro, which belongs to the Zacks Toys - Games - Hobbies industry, posted revenues of $1.14 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 8.93%. This compares to year-ago revenues of $980.8 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Hasbro shares have lost about 0.5% since the beginning of the year versus the S&P 500's gain of 8.7%.

What's Next for Hasbro?While Hasbro has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Hasbro was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.87 on $1.5 billion in revenues for the coming quarter and $6.04 on $4.99 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Toys - Games - Hobbies is currently in the top 3% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Jakks Pacific (JAKK - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026. The results are expected to be released on July 23.

This toymaker is expected to post quarterly earnings of $0.25 per share in its upcoming report, which represents a year-over-year change of +733.3%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Jakks Pacific's revenues are expected to be $129.62 million, up 8.8% from the year-ago quarter.

Posted by Defense World Staff on Jul 21st, 2026

Chicago Partners Investment Group LLC purchased a new stake in Cipher Mining Inc. (NASDAQ:CIFR – Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 25,068 shares of the company’s stock, valued at approximately $323,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Los Angeles Capital Management LLC acquired a new position in shares of Cipher Mining in the 4th quarter valued at about $25,000. Arax Advisory Partners lifted its position in shares of Cipher Mining by 274.2% in the fourth quarter. Arax Advisory Partners now owns 1,826 shares of the company’s stock worth $27,000 after buying an additional 1,338 shares during the last quarter. GAMMA Investing LLC lifted its holdings in Cipher Mining by 218.3% in the 4th quarter. GAMMA Investing LLC now owns 1,875 shares of the company’s stock worth $28,000 after purchasing an additional 1,286 shares during the last quarter. Meeder Asset Management Inc. bought a new stake in shares of Cipher Mining during the 4th quarter worth $28,000. Finally, Danske Bank A S boosted its holdings in Cipher Mining by 1,150.0% during the fourth quarter. Danske Bank A S now owns 2,500 shares of the company’s stock valued at $37,000 after acquiring an additional 2,300 shares during the period. Institutional investors and hedge funds own 12.26% of the company’s stock.

Insider Activity at Cipher Mining In related news, Director Cary M. Grossman sold 15,000 shares of Cipher Mining stock in a transaction that occurred on Thursday, June 18th. The stock was sold at an average price of $29.43, for a total value of $441,450.00. Following the sale, the director owned 143,829 shares of the company’s stock, valued at approximately $4,232,887.47. This trade represents a 9.44% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director James E. Newsome sold 3,758 shares of the business’s stock in a transaction on Tuesday, June 16th. The stock was sold at an average price of $26.60, for a total transaction of $99,962.80. Following the completion of the sale, the director directly owned 128,530 shares in the company, valued at approximately $3,418,898. This represents a 2.84% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 3,245,336 shares of company stock valued at $83,803,938 over the last three months. Insiders own 2.63% of the company’s stock.

Analyst Upgrades and Downgrades Several research firms have recently weighed in on CIFR. Keefe, Bruyette & Woods increased their price objective on Cipher Mining from $23.00 to $27.00 and gave the company an “outperform” rating in a research report on Thursday, May 7th. HC Wainwright upped their price objective on Cipher Mining from $25.00 to $30.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Cantor Fitzgerald dropped their target price on shares of Cipher Mining from $24.00 to $22.00 and set an “overweight” rating for the company in a research report on Thursday, April 9th. Morgan Stanley cut their price objective on Cipher Mining from $48.50 to $47.00 and set an “overweight” rating for the company in a research report on Monday. Finally, BTIG Research boosted their target price on shares of Cipher Mining from $25.00 to $35.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Cipher Mining currently has an average rating of “Moderate Buy” and a consensus price target of $28.22.

Get Our Latest Research Report on Cipher Mining

Cipher Mining Stock Up 17.0% Cipher Mining stock opened at $20.54 on Tuesday. Cipher Mining Inc. has a fifty-two week low of $4.55 and a fifty-two week high of $30.14. The firm has a market capitalization of $8.40 billion, a price-to-earnings ratio of -8.82 and a beta of 3.18. The company has a debt-to-equity ratio of 6.13, a current ratio of 3.13 and a quick ratio of 3.13. The company’s 50 day simple moving average is $23.02 and its 200 day simple moving average is $18.71.

Cipher Mining (NASDAQ:CIFR – Get Free Report) last released its quarterly earnings data on Tuesday, May 5th. The company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). The firm had revenue of $34.84 million during the quarter, compared to the consensus estimate of $36.12 million. Cipher Mining had a negative net margin of 427.79% and a negative return on equity of 117.65%. The business’s quarterly revenue was down 28.8% on a year-over-year basis. As a group, sell-side analysts anticipate that Cipher Mining Inc. will post -0.8 EPS for the current year.

Cipher Mining Company Profile (Free Report)

Cipher Mining Inc is a Nasdaq-listed bitcoin mining company that develops, owns and operates large-scale mining facilities across the United States. The company focuses on deploying advanced ASIC hardware and securing long-term low-cost power contracts to optimize bitcoin production. By strategically locating its sites in regions with abundant energy supply, Cipher Mining seeks to maintain a competitive cost structure and deliver efficient hashrate capacity growth.

Founded in 2021 and headquartered in Austin, Texas, Cipher Mining has pursued an integrated approach encompassing site development, equipment procurement and operations management.

Featured Stories Five stocks we like better than Cipher Mining The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Cipher Mining Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Mining and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEFifth Third Bancorp Has $2.87 Million Holdings in Pinterest, Inc. $PINS

NEXT HEADLINE »Fifth Third Bancorp Takes $2.77 Million Position in JPMorgan U.S. Quality Factor ETF $JQUA

Posted by Defense World Staff on Jul 21st, 2026

Bank of New York Mellon Corp lowered its stake in Corpay, Inc (NYSE:CPAY – Free Report) by 2.3% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 343,074 shares of the corporate payments company’s stock after selling 8,074 shares during the quarter. Bank of New York Mellon Corp owned about 0.50% of Corpay worth $99,831,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in CPAY. Generate Investment Management Ltd increased its stake in shares of Corpay by 60.0% in the 4th quarter. Generate Investment Management Ltd now owns 120,000 shares of the corporate payments company’s stock valued at $36,112,000 after purchasing an additional 45,000 shares during the last quarter. Pensionfund Sabic bought a new stake in shares of Corpay during the 4th quarter worth $1,113,000. Louisiana State Employees Retirement System bought a new stake in shares of Corpay during the 1st quarter worth $1,048,000. Moran Wealth Management LLC boosted its stake in Corpay by 77.9% in the first quarter. Moran Wealth Management LLC now owns 37,869 shares of the corporate payments company’s stock valued at $11,020,000 after buying an additional 16,586 shares in the last quarter. Finally, M&T Bank Corp boosted its stake in Corpay by 4,657.7% in the fourth quarter. M&T Bank Corp now owns 1,044,074 shares of the corporate payments company’s stock valued at $314,193,000 after buying an additional 1,022,129 shares in the last quarter. 98.84% of the stock is currently owned by institutional investors.

Analyst Ratings Changes A number of brokerages have recently commented on CPAY. Robert W. Baird dropped their price target on Corpay from $440.00 to $380.00 and set an “outperform” rating for the company in a research note on Tuesday, March 31st. Loop Capital assumed coverage on Corpay in a research report on Monday, May 18th. They issued a “buy” rating and a $406.00 target price for the company. Oppenheimer reissued an “outperform” rating and set a $388.00 price target on shares of Corpay in a research note on Friday, May 8th. Wolfe Research restated an “outperform” rating and set a $450.00 price target on shares of Corpay in a report on Wednesday, June 3rd. Finally, Weiss Ratings raised Corpay from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, April 27th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $382.54.

Check Out Our Latest Stock Analysis on CPAY

Insider Transactions at Corpay In other news, Director Steven T. Stull sold 1,000 shares of Corpay stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $360.78, for a total value of $360,780.00. Following the completion of the transaction, the director directly owned 28,241 shares of the company’s stock, valued at approximately $10,188,787.98. This trade represents a 3.42% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Armando Lins Netto sold 70,476 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $352.13, for a total value of $24,816,713.88. Following the sale, the insider directly owned 11,274 shares of the company’s stock, valued at $3,969,913.62. This represents a 86.21% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 88,677 shares of company stock valued at $31,304,091. Company insiders own 5.19% of the company’s stock.

Corpay Price Performance Shares of CPAY opened at $368.87 on Tuesday. The business has a 50-day moving average of $349.53 and a 200-day moving average of $332.61. The company has a debt-to-equity ratio of 1.86, a current ratio of 0.98 and a quick ratio of 0.98. The company has a market capitalization of $24.11 billion, a price-to-earnings ratio of 22.07, a price-to-earnings-growth ratio of 1.00 and a beta of 0.88. Corpay, Inc has a 1 year low of $252.84 and a 1 year high of $374.09.

Corpay (NYSE:CPAY – Get Free Report) last released its earnings results on Thursday, May 14th. The corporate payments company reported ($0.01) earnings per share for the quarter. The firm had revenue of $5.63 million for the quarter. Corpay had a net margin of 24.60% and a return on equity of 38.68%. As a group, equities research analysts anticipate that Corpay, Inc will post 25.49 earnings per share for the current year.

Corpay Profile (Free Report)

Corpay is a global corporate payments company that provides businesses with a range of payment and expense management solutions. Its services are designed to help organizations manage payables, card programs, travel and fleet-related expenses, and cross-border transactions more efficiently.

The company serves customers across a variety of industries and geographies, offering software and payment tools that streamline accounts payable, vendor payments, and workforce payments. Corpay also provides specialized solutions for fleet management and international payments, helping businesses control costs and simplify financial operations.

Corpay operates as part of the broader financial technology and payment processing sector.

Read More Five stocks we like better than Corpay The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding CPAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corpay, Inc (NYSE:CPAY – Free Report).

Receive News & Ratings for Corpay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corpay and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEApple Inc. $AAPL Holdings Reduced by Childress Capital Advisors LLC

NEXT HEADLINE »Baader Bank Aktiengesellschaft Decreases Stake in Arista Networks, Inc. $ANET

Posted by Defense World Staff on Jul 21st, 2026

Bessemer Group Inc. increased its stake in shares of Insight Enterprises, Inc. (NASDAQ:NSIT – Free Report) by 45.1% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 63,266 shares of the software maker’s stock after purchasing an additional 19,664 shares during the period. Bessemer Group Inc. owned 0.21% of Insight Enterprises worth $4,239,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Royal Bank of Canada boosted its stake in shares of Insight Enterprises by 684.8% in the first quarter. Royal Bank of Canada now owns 24,422 shares of the software maker’s stock worth $3,664,000 after acquiring an additional 21,310 shares during the last quarter. AQR Capital Management LLC raised its stake in Insight Enterprises by 39.7% in the 1st quarter. AQR Capital Management LLC now owns 15,097 shares of the software maker’s stock valued at $2,264,000 after purchasing an additional 4,293 shares during the last quarter. Integrated Wealth Concepts LLC purchased a new position in Insight Enterprises in the 1st quarter valued at $221,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Insight Enterprises by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,216 shares of the software maker’s stock valued at $2,432,000 after purchasing an additional 714 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Insight Enterprises by 5.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 74,259 shares of the software maker’s stock worth $11,138,000 after buying an additional 3,722 shares in the last quarter.

Insight Enterprises Stock Down 1.0% NSIT stock opened at $114.19 on Tuesday. The stock has a market cap of $3.45 billion, a P/E ratio of 19.96, a PEG ratio of 1.06 and a beta of 1.08. The company has a current ratio of 1.22, a quick ratio of 1.17 and a debt-to-equity ratio of 0.92. Insight Enterprises, Inc. has a twelve month low of $63.62 and a twelve month high of $148.58. The company’s 50 day moving average is $108.61 and its two-hundred day moving average is $89.63.

Insight Enterprises (NASDAQ:NSIT – Get Free Report) last issued its earnings results on Thursday, May 7th. The software maker reported $2.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.45 by $0.43. The business had revenue of $2.13 billion during the quarter, compared to analysts’ expectations of $2.12 billion. Insight Enterprises had a net margin of 2.17% and a return on equity of 20.89%. The company’s revenue for the quarter was up 1.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.06 EPS. Insight Enterprises has set its FY 2026 guidance at 11.000-11.500 EPS. Research analysts expect that Insight Enterprises, Inc. will post 10.89 earnings per share for the current fiscal year.

Analyst Ratings Changes Several research firms have recently weighed in on NSIT. Wall Street Zen raised shares of Insight Enterprises from a “hold” rating to a “buy” rating in a research note on Sunday, May 10th. Canaccord Genuity Group set a $75.00 target price on Insight Enterprises in a research note on Friday, May 8th. Raymond James Financial raised shares of Insight Enterprises from a “market perform” rating to an “outperform” rating and set a $100.00 price objective for the company in a research report on Thursday, May 7th. Weiss Ratings upgraded Insight Enterprises from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, June 17th. Finally, JPMorgan Chase & Co. raised Insight Enterprises from an “underweight” rating to a “neutral” rating and set a $105.00 target price for the company in a research report on Wednesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Insight Enterprises currently has an average rating of “Moderate Buy” and an average price target of $100.00.

Read Our Latest Research Report on Insight Enterprises

Insider Activity at Insight Enterprises In other news, CFO James A. Morgado acquired 2,290 shares of the business’s stock in a transaction on Monday, May 11th. The stock was bought at an average price of $87.25 per share, for a total transaction of $199,802.50. Following the transaction, the chief financial officer owned 17,246 shares in the company, valued at $1,504,713.50. This represents a 15.31% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. 1.21% of the stock is owned by company insiders.

Insight Enterprises Company Profile (Free Report)

Insight Enterprises, Inc is a global technology provider headquartered in Tempe, Arizona. Founded in 1988, the company specializes in helping organizations harness the power of digital transformation by offering a comprehensive portfolio of IT hardware, software, cloud and licensing management solutions. Insight’s expertise spans across the full technology lifecycle, from initial strategy and consulting to implementation, integration and ongoing managed services.

At the core of Insight’s business are its consulting and professional services, which guide clients through complex technology environments and ensure optimal deployment of solutions.

Further Reading Five stocks we like better than Insight Enterprises The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding NSIT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Insight Enterprises, Inc. (NASDAQ:NSIT – Free Report).

Receive News & Ratings for Insight Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Insight Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBalefire LLC Sells 55,504 Shares of SPDR Bloomberg Short Term High Yield Bond ETF $SJNK

NEXT HEADLINE »Bessemer Group Inc. Acquires 17,795 Shares of iShares Core MSCI Europe ETF $IEUR

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Verra To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Verra between February 24, 2026 and May 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

New York, New York--(Newsfile Corp. - July 21, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Verra Mobility Corporation ("Verra" or the "Company") (NASDAQ: VRRM) and reminds investors of the August 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Verra's relationship with Avis Budget Group ("Avis"), and in particular obtaining a contract extension with Avis. Further, the Company minimized concerns that major rent-a-cars could replace Verra with in-house solutions or outsourced alternatives.

On May 26, 2026, Verra issued a press release announcing a termination notice from Avis regarding its contract and accordingly lowered its 2026 full-year financial outlook. Almost one week later on June 1, 2026, the Company announced a sudden and surprising transition of its President and Chief Executive Officer David Roberts. Following this news, the price of Verra's common stock declined dramatically.

From a closing market price of $13.08 per share on May 26, 2026, Verra's stock price fell to $3.85 per share on May 27, 2026, a decline of about 71%.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Verra's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Verra class action, go to www.faruqilaw.com/VRRM or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Frequently Asked Questions (FAQ) for Investors Regarding the Verra Mobility Securities Class Action Lawsuit:

What is the Verra Mobility securities fraud lawsuit about?

The lawsuit alleges Verra Mobility misled investors about the strength of its relationship with Avis Budget Group, the likelihood of a contract extension, and the risk that major rental car companies could replace Verra's services with alternative solutions.

Who may be eligible to participate in the lawsuit?

Investors who purchased or acquired Verra Mobility (NASDAQ: VRRM) securities between February 24, 2026 and May 26, 2026 may be eligible to participate if they suffered losses related to the alleged misconduct described in the complaint.

What is a lead plaintiff, and how can I seek appointment?

A lead plaintiff represents the interests of the proposed class and helps oversee the litigation. Investors seeking appointment must file a motion with the court by August 4, 2026. Investors can share in any recovery without serving as lead plaintiff.

What should investors do if they purchased Verra Mobility stock during the Class Period?

Investors should review their transaction records, preserve relevant documents, and evaluate their legal rights. Those who suffered losses may wish to consult counsel regarding participation in the lawsuit or seeking lead plaintiff status before the deadline.

Why should investors contact Faruqi & Faruqi, LLP?

Faruqi & Faruqi, LLP has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for shareholders. Investors who purchased Verra Mobility securities during the Class Period may contact the firm to discuss their legal rights, potential claims, and the lead plaintiff process at no cost or obligation.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305854

Source: Faruqi & Faruqi LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Delivers scalable datacenter connectivity, increased capacity, and reduced power consumption

, /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global leader in real-time communications technology, IP routing and optical networking solutions, today announced that leading Indonesia provider PT Jala Lintas Media (JLM) is leveraging Ribbon's Apollo platform for a greenfield DWDM network deployment connecting Indonesia and Singapore. JLM is also utilizing Ribbon's Data Center Interconnect (DCI) solution to deliver scalable, high-capacity connectivity for cloud and AI workloads. This deployment marks the first phase of a broader network expansion being implemented with support from PT Mahavira System Integra.

"Ribbon brought together advanced technology and exceptional execution," said Victor Irianto, Founder and President Commissioner of JLM. "Their solution was the most technically advanced we evaluated, while also delivering a smaller footprint, reduced power consumption, and the fastest delivery, implementation, testing, and integration process. With Ribbon's DCI capabilities now connecting datacenters across Indonesia and Singapore, we are well positioned to scale efficiently and deliver increased value to our customers."

JLM is leveraging Ribbon's powerful and highly versatile Apollo 9608 modular optical networking platform for metro, core, and data center interconnect (DCI) applications. As a key component of Ribbon's industry-leading DCI solution, the Apollo 9608 delivers exceptional scalability, high-density performance, and low power consumption, enabling efficient and cost-effective network expansion.

"Offering the best technology is no longer sufficient in today's environment. Service providers are facing extended deployment lead times that can impact revenue opportunities, service delivery and customer satisfaction," said Mickey Wilf, Head of ASEAN Sales at Ribbon. "Ribbon combines high performance optical innovation with rapid deployment and proven DCI expertise. We're proud to support JLM as it expands its network infrastructure and strengthens connectivity between its datacenters in Indonesia and Singapore."

About Ribbon
Ribbon Communications (Nasdaq: RBBN) is a global provider of voice communications software, IP routing, and optical networking to mobile and wireline service providers, enterprises, critical infrastructure and defense sectors. We support our customers' Path to Autonomous Networks by leveraging the latest AIOps automation platforms and Agentic AI technologies, helping them deliver better customer experiences, reduce operational costs, and achieve sustainable growth. To learn more about Ribbon, visit rbbn.com.

Important Information Regarding Forward-Looking Statements 
The information in this release contains forward-looking statements regarding future events that involve risks and uncertainties. All statements other than statements of historical facts contained in this release, including those regarding the expected benefits from use of Ribbon Communication's products, are forward-looking statements. The actual results of Ribbon Communications may differ materially from those contemplated by the forward-looking statements. For further information regarding risks and uncertainties associated with Ribbon Communications' business, please refer to the "Risk Factors" section of Ribbon Communications' most recent annual or quarterly report filed with the SEC. Any forward-looking statements represent Ribbon Communications' views only as of the date on which such statement is made and should not be relied upon as representing Ribbon Communications' views as of any subsequent date. While Ribbon Communications may elect to update forward-looking statements at some point, Ribbon Communications specifically disclaims any obligation to do so.

Investor Contact
+1 (978) 614-8050
[email protected] 

Media Contact
Catherine Berthier
+1 (646) 741-1974
[email protected] 

SOURCE Ribbon Communications Inc.

Posted by Defense World Staff on Jul 21st, 2026

Bessemer Group Inc. reduced its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 59.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 48,062 shares of the company’s stock after selling 69,600 shares during the period. Bessemer Group Inc.’s holdings in Revolution Medicines were worth $4,675,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of RVMD. Vanguard Group Inc. boosted its stake in Revolution Medicines by 6.7% in the fourth quarter. Vanguard Group Inc. now owns 16,719,886 shares of the company’s stock worth $1,331,739,000 after purchasing an additional 1,056,792 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its stake in shares of Revolution Medicines by 194.6% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 21,289 shares of the company’s stock valued at $1,696,000 after buying an additional 14,062 shares in the last quarter. Mass General Brigham Inc bought a new position in shares of Revolution Medicines in the fourth quarter valued at about $27,407,000. Eagle Health Investments LP acquired a new position in Revolution Medicines during the 4th quarter worth about $9,231,000. Finally, M&T Bank Corp acquired a new position in Revolution Medicines during the 4th quarter worth about $52,723,000. 94.34% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets RVMD has been the topic of a number of research analyst reports. Evercore reissued an “outperform” rating on shares of Revolution Medicines in a report on Tuesday, April 14th. Truist Financial upped their target price on shares of Revolution Medicines from $179.00 to $210.00 and gave the stock a “buy” rating in a research report on Tuesday, June 30th. Piper Sandler increased their price target on shares of Revolution Medicines to $172.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Oppenheimer raised their price target on shares of Revolution Medicines from $165.00 to $195.00 and gave the company an “outperform” rating in a report on Monday, June 1st. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Revolution Medicines in a research report on Tuesday, April 21st. Two research analysts have rated the stock with a Strong Buy rating, eighteen have given a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Revolution Medicines presently has a consensus rating of “Moderate Buy” and a consensus price target of $144.06.

Get Our Latest Research Report on RVMD

Insider Activity In other news, Director Sushil Patel sold 5,580 shares of the firm’s stock in a transaction dated Monday, June 29th. The stock was sold at an average price of $187.99, for a total transaction of $1,048,984.20. Following the sale, the director owned 21,656 shares of the company’s stock, valued at $4,071,111.44. This trade represents a 20.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Mark A. Goldsmith sold 10,020 shares of Revolution Medicines stock in a transaction dated Tuesday, June 16th. The shares were sold at an average price of $156.12, for a total value of $1,564,322.40. Following the transaction, the insider owned 267,330 shares in the company, valued at $41,735,559.60. This trade represents a 3.61% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 132,497 shares of company stock valued at $21,470,486. Company insiders own 7.60% of the company’s stock.

Revolution Medicines Stock Down 3.1% NASDAQ:RVMD opened at $180.39 on Tuesday. The company has a quick ratio of 6.80, a current ratio of 6.80 and a debt-to-equity ratio of 0.19. Revolution Medicines, Inc. has a 12-month low of $34.00 and a 12-month high of $193.82. The stock’s fifty day simple moving average is $165.80 and its 200-day simple moving average is $129.09. The firm has a market capitalization of $38.35 billion, a P/E ratio of -25.51 and a beta of 1.37.

Revolution Medicines (NASDAQ:RVMD – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported ($2.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.83) by ($0.46). During the same quarter last year, the business posted ($1.13) EPS. Equities research analysts expect that Revolution Medicines, Inc. will post -7.92 earnings per share for the current year.

About Revolution Medicines (Free Report)

Revolution Medicines is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapies to treat RAS-dependent cancers and other diseases driven by the RAS/MAPK pathway. The company’s research efforts target historically “undruggable” proteins, aiming to inhibit critical nodes in cell signaling that promote tumor growth and therapeutic resistance.

The lead pipeline includes RMC-4630, a SHP2 inhibitor; RMC-6291, a selective KRAS G12C inhibitor; and RMC-6236, a pan-RAS inhibitor designed to address multiple RAS mutations.

Featured Stories Five stocks we like better than Revolution Medicines The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Revolution Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revolution Medicines and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEFifth Third Bancorp Raises Stock Holdings in SPDR Portfolio High Yield Bond ETF $SPHY

NEXT HEADLINE »Bessemer Group Inc. Increases Position in Highwoods Properties, Inc. $HIW

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Considering buying INSM stock? Here’s what analysts think:

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Posted by Defense World Staff on Jul 21st, 2026

California Public Employees Retirement System lessened its stake in shares of Darden Restaurants, Inc. (NYSE:DRI – Free Report) by 13.6% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 248,100 shares of the restaurant operator’s stock after selling 39,143 shares during the quarter. California Public Employees Retirement System owned about 0.22% of Darden Restaurants worth $48,638,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of DRI. Torren Management LLC bought a new position in shares of Darden Restaurants in the fourth quarter valued at approximately $26,000. Thurston Springer Miller Herd & Titak Inc. grew its stake in Darden Restaurants by 926.7% during the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 154 shares of the restaurant operator’s stock valued at $28,000 after acquiring an additional 139 shares in the last quarter. Union Savings Bank bought a new stake in Darden Restaurants during the 4th quarter worth approximately $28,000. BOK Financial Private Wealth Inc. bought a new stake in Darden Restaurants during the 4th quarter worth approximately $29,000. Finally, DV Equities LLC purchased a new stake in Darden Restaurants in the 4th quarter worth approximately $30,000. 93.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling In related news, SVP Susan M. Connelly sold 9,930 shares of the company’s stock in a transaction on Tuesday, July 7th. The shares were sold at an average price of $206.21, for a total transaction of $2,047,665.30. Following the completion of the sale, the senior vice president directly owned 4,165 shares in the company, valued at $858,864.65. This represents a 70.45% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.49% of the stock is owned by corporate insiders.

Darden Restaurants Stock Down 1.9% DRI opened at $194.77 on Tuesday. Darden Restaurants, Inc. has a 12 month low of $169.00 and a 12 month high of $220.65. The company has a current ratio of 0.31, a quick ratio of 0.21 and a debt-to-equity ratio of 0.74. The business’s 50-day moving average price is $202.86 and its 200-day moving average price is $202.80. The company has a market cap of $22.31 billion, a P/E ratio of 18.76, a P/E/G ratio of 1.98 and a beta of 0.60.

Darden Restaurants (NYSE:DRI – Get Free Report) last announced its quarterly earnings data on Thursday, June 25th. The restaurant operator reported $3.66 earnings per share for the quarter, beating the consensus estimate of $3.63 by $0.03. The firm had revenue of $3.72 billion during the quarter, compared to the consensus estimate of $3.73 billion. Darden Restaurants had a return on equity of 57.44% and a net margin of 9.13%.The business’s revenue was up 13.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.98 earnings per share. Darden Restaurants has set its FY 2027 guidance at 11.100-11.350 EPS. On average, equities analysts expect that Darden Restaurants, Inc. will post 11.28 EPS for the current year.

Darden Restaurants Increases Dividend The company also recently announced a quarterly dividend, which will be paid on Monday, August 3rd. Investors of record on Friday, July 10th will be paid a $1.62 dividend. The ex-dividend date of this dividend is Friday, July 10th. This is a positive change from Darden Restaurants’s previous quarterly dividend of $1.50. This represents a $6.48 annualized dividend and a dividend yield of 3.3%. Darden Restaurants’s payout ratio is presently 62.43%.

Analyst Upgrades and Downgrades A number of research firms have recently commented on DRI. Robert W. Baird boosted their price target on shares of Darden Restaurants from $210.00 to $220.00 and gave the company a “neutral” rating in a research report on Friday, June 26th. Guggenheim increased their price objective on Darden Restaurants from $230.00 to $235.00 and gave the stock a “buy” rating in a research report on Wednesday, June 24th. Deutsche Bank Aktiengesellschaft lifted their price objective on Darden Restaurants from $230.00 to $236.00 and gave the company a “buy” rating in a research note on Friday, June 26th. Stephens boosted their target price on Darden Restaurants from $210.00 to $216.00 and gave the stock an “equal weight” rating in a research report on Friday, June 26th. Finally, Evercore lowered Darden Restaurants from an “outperform” rating to an “in-line” rating and set a $230.00 target price on the stock. in a research note on Tuesday, June 23rd. Seventeen investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $228.88.

Get Our Latest Analysis on DRI

Darden Restaurants Profile (Free Report)

Darden Restaurants, Inc is a multi-brand, full-service restaurant company headquartered in Orlando, Florida. The company owns and operates a portfolio of casual and fine-dining concepts that together serve millions of guests through company-owned and franchised locations. Its well-known brands include Olive Garden and LongHorn Steakhouse, alongside other dining concepts that span Italian, American, steakhouse and upscale casual formats.

Darden’s restaurants provide a range of guest-facing services including dine-in, takeout, delivery and catering, and feature menus tailored to each brand’s positioning—Italian-American fare at Olive Garden, steaks and grilled items at LongHorn, and more premium steakhouse and chef-driven offerings at its upscale concepts.

Featured Articles Five stocks we like better than Darden Restaurants The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Darden Restaurants Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Darden Restaurants and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEStrategy Inc $MSTR Stake Cut by California Public Employees Retirement System

NEXT HEADLINE »California Public Employees Retirement System Sells 171,322 Shares of NiSource, Inc $NI

Posted by Defense World Staff on Jul 21st, 2026

Bank of New York Mellon Corp lowered its holdings in shares of Tenet Healthcare Corporation (NYSE:THC – Free Report) by 6.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 606,242 shares of the company’s stock after selling 40,155 shares during the period. Bank of New York Mellon Corp owned approximately 0.69% of Tenet Healthcare worth $114,404,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in THC. Livforsakringsbolaget Skandia Omsesidigt increased its holdings in shares of Tenet Healthcare by 11.4% during the first quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 43,050 shares of the company’s stock valued at $8,124,000 after acquiring an additional 4,400 shares in the last quarter. Sanctuary Advisors LLC grew its position in Tenet Healthcare by 0.5% in the 1st quarter. Sanctuary Advisors LLC now owns 11,900 shares of the company’s stock valued at $2,246,000 after purchasing an additional 57 shares during the period. Hillsdale Investment Management Inc. increased its stake in Tenet Healthcare by 3.3% during the 1st quarter. Hillsdale Investment Management Inc. now owns 28,390 shares of the company’s stock valued at $5,357,000 after purchasing an additional 900 shares in the last quarter. Archer Investment Corp bought a new position in shares of Tenet Healthcare in the first quarter valued at $113,000. Finally, State of Michigan Retirement System grew its holdings in shares of Tenet Healthcare by 1.9% during the first quarter. State of Michigan Retirement System now owns 21,193 shares of the company’s stock valued at $3,999,000 after buying an additional 400 shares during the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades A number of research firms recently weighed in on THC. TD Cowen dropped their price target on shares of Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating on the stock in a research report on Monday, June 22nd. Barclays increased their price objective on shares of Tenet Healthcare from $238.00 to $240.00 and gave the company an “overweight” rating in a research note on Wednesday, July 8th. Royal Bank Of Canada reduced their target price on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a report on Friday, May 1st. Stephens dropped their price target on Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating on the stock in a report on Monday, May 4th. Finally, KeyCorp reduced their price objective on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Eighteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $244.84.

Get Our Latest Report on Tenet Healthcare

Tenet Healthcare Stock Down 0.2% THC opened at $194.43 on Tuesday. The company has a 50 day moving average of $184.41 and a 200 day moving average of $197.41. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. Tenet Healthcare Corporation has a 12 month low of $146.60 and a 12 month high of $247.21. The company has a market cap of $16.75 billion, a PE ratio of 10.11, a price-to-earnings-growth ratio of 1.61 and a beta of 1.27.

Tenet Healthcare (NYSE:THC – Get Free Report) last issued its earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.39 billion. During the same quarter last year, the company earned $4.36 EPS. The firm’s revenue was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, sell-side analysts expect that Tenet Healthcare Corporation will post 17.5 EPS for the current year.

Insider Buying and Selling at Tenet Healthcare In other news, Director Nadja West sold 3,000 shares of the stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total transaction of $532,050.00. Following the transaction, the director directly owned 24,805 shares in the company, valued at approximately $4,399,166.75. This represents a 10.79% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the sale, the director owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. The trade was a 25.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.97% of the company’s stock.

Tenet Healthcare Profile (Free Report)

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

Recommended Stories Five stocks we like better than Tenet Healthcare The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBalefire LLC Reduces Position in Lockheed Martin Corporation $LMT

NEXT HEADLINE »Baader Bank Aktiengesellschaft Sells 2,719 Shares of S&P Global Inc. $SPGI